Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Interfering | 9 | 2025 | 987 | 1.710 |
Why?
|
| Rabies virus | 3 | 2022 | 9 | 1.030 |
Why?
|
| Huntington Disease | 4 | 2024 | 164 | 1.010 |
Why?
|
| Extracellular Matrix | 3 | 2025 | 148 | 0.850 |
Why?
|
| Rabies | 2 | 2021 | 8 | 0.850 |
Why?
|
| Nucleic Acids | 1 | 2024 | 67 | 0.780 |
Why?
|
| Oligonucleotides | 3 | 2023 | 229 | 0.700 |
Why?
|
| Phosphatidylcholines | 1 | 2021 | 39 | 0.690 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2021 | 3 | 0.680 |
Why?
|
| Molecular Imaging | 1 | 2021 | 52 | 0.670 |
Why?
|
| Mesoderm | 1 | 2021 | 89 | 0.650 |
Why?
|
| Cell Movement | 3 | 2025 | 482 | 0.650 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 118 | 0.650 |
Why?
|
| Mice | 24 | 2026 | 11173 | 0.620 |
Why?
|
| Mass Spectrometry | 1 | 2021 | 296 | 0.620 |
Why?
|
| Fibroblasts | 1 | 2021 | 423 | 0.570 |
Why?
|
| Ascorbic Acid | 3 | 2022 | 53 | 0.510 |
Why?
|
| Animals | 26 | 2026 | 21459 | 0.480 |
Why?
|
| Nitrogen Oxides | 1 | 2015 | 11 | 0.460 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 89 | 0.440 |
Why?
|
| Biomarkers | 4 | 2026 | 1487 | 0.390 |
Why?
|
| Contrast Media | 1 | 2015 | 432 | 0.380 |
Why?
|
| Oxidation-Reduction | 4 | 2025 | 328 | 0.370 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 1233 | 0.350 |
Why?
|
| Insulin-Secreting Cells | 2 | 2026 | 195 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 10 | 2026 | 3500 | 0.340 |
Why?
|
| RNA, Messenger | 3 | 2025 | 1580 | 0.310 |
Why?
|
| Lysine | 2 | 2019 | 93 | 0.290 |
Why?
|
| Huntingtin Protein | 3 | 2024 | 151 | 0.290 |
Why?
|
| Genetic Vectors | 2 | 2026 | 929 | 0.280 |
Why?
|
| Dependovirus | 2 | 2026 | 760 | 0.280 |
Why?
|
| Alleles | 4 | 2022 | 455 | 0.270 |
Why?
|
| RNA Interference | 3 | 2025 | 647 | 0.260 |
Why?
|
| Capsid | 2 | 2026 | 104 | 0.260 |
Why?
|
| Brain | 1 | 2015 | 1625 | 0.250 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2025 | 148 | 0.250 |
Why?
|
| Dasatinib | 1 | 2026 | 7 | 0.240 |
Why?
|
| Abatacept | 1 | 2026 | 67 | 0.240 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 2262 | 0.240 |
Why?
|
| Purines | 1 | 2026 | 43 | 0.240 |
Why?
|
| Factor VIII | 2 | 2023 | 32 | 0.230 |
Why?
|
| Gene Transfer Techniques | 2 | 2026 | 325 | 0.230 |
Why?
|
| Myostatin | 1 | 2025 | 20 | 0.230 |
Why?
|
| Volatile Organic Compounds | 1 | 2025 | 22 | 0.220 |
Why?
|
| Acetaminophen | 2 | 2025 | 53 | 0.220 |
Why?
|
| Podocytes | 1 | 2024 | 12 | 0.220 |
Why?
|
| Pericytes | 1 | 2025 | 17 | 0.220 |
Why?
|
| Humans | 21 | 2026 | 65645 | 0.220 |
Why?
|
| Capillaries | 1 | 2025 | 35 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2026 | 679 | 0.210 |
Why?
|
| Gene Silencing | 5 | 2025 | 436 | 0.210 |
Why?
|
| Iron | 1 | 2025 | 155 | 0.210 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2024 | 8 | 0.210 |
Why?
|
| Integrin alpha5beta1 | 2 | 2023 | 6 | 0.200 |
Why?
|
| Immunosuppressive Agents | 1 | 2026 | 381 | 0.200 |
Why?
|
| Stress, Physiological | 1 | 2026 | 210 | 0.200 |
Why?
|
| Liver | 3 | 2025 | 874 | 0.200 |
Why?
|
| Cell Adhesion | 2 | 2021 | 218 | 0.200 |
Why?
|
| Myocardium | 1 | 2025 | 302 | 0.200 |
Why?
|
| Superoxide Dismutase | 2 | 2025 | 223 | 0.200 |
Why?
|
| Transduction, Genetic | 1 | 2024 | 242 | 0.190 |
Why?
|
| Organophosphorus Compounds | 1 | 2023 | 33 | 0.190 |
Why?
|
| Hemophilia A | 1 | 2023 | 57 | 0.190 |
Why?
|
| Lipids | 1 | 2025 | 330 | 0.190 |
Why?
|
| Cartilage, Articular | 1 | 2023 | 79 | 0.190 |
Why?
|
| Peptide Initiation Factors | 2 | 2019 | 37 | 0.190 |
Why?
|
| PPAR alpha | 1 | 2022 | 33 | 0.190 |
Why?
|
| Liver Diseases | 1 | 2024 | 157 | 0.190 |
Why?
|
| Interleukin-15 | 1 | 2022 | 25 | 0.180 |
Why?
|
| Viral Matrix Proteins | 1 | 2022 | 50 | 0.180 |
Why?
|
| Central Nervous System | 1 | 2024 | 200 | 0.180 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2021 | 15 | 0.180 |
Why?
|
| Organophosphonates | 1 | 2021 | 22 | 0.180 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2021 | 28 | 0.170 |
Why?
|
| Osteoarthritis | 1 | 2023 | 146 | 0.170 |
Why?
|
| RAW 264.7 Cells | 1 | 2021 | 50 | 0.170 |
Why?
|
| Glutathione | 1 | 2021 | 55 | 0.170 |
Why?
|
| Apolipoprotein A-I | 1 | 2021 | 23 | 0.170 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2021 | 89 | 0.170 |
Why?
|
| Phospholipids | 1 | 2021 | 81 | 0.170 |
Why?
|
| Aldehyde Reductase | 1 | 2021 | 3 | 0.170 |
Why?
|
| Corticosterone | 1 | 2021 | 24 | 0.170 |
Why?
|
| Fetal Growth Retardation | 1 | 2021 | 21 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2026 | 630 | 0.160 |
Why?
|
| Cell Nucleus | 1 | 2024 | 634 | 0.160 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 788 | 0.160 |
Why?
|
| Pregnancy-Specific beta 1-Glycoproteins | 1 | 2019 | 1 | 0.150 |
Why?
|
| Dog Diseases | 1 | 2020 | 47 | 0.150 |
Why?
|
| Polyamines | 1 | 2019 | 13 | 0.150 |
Why?
|
| Trophoblasts | 1 | 2019 | 9 | 0.150 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2025 | 517 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2026 | 714 | 0.150 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 327 | 0.150 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2019 | 3 | 0.150 |
Why?
|
| RNA-Binding Proteins | 2 | 2019 | 446 | 0.140 |
Why?
|
| Genes, Recessive | 1 | 2019 | 51 | 0.140 |
Why?
|
| Adenosine Deaminase | 1 | 2018 | 22 | 0.140 |
Why?
|
| RNA Editing | 1 | 2018 | 27 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 50 | 0.140 |
Why?
|
| DNA | 1 | 2023 | 853 | 0.140 |
Why?
|
| RNA, Double-Stranded | 1 | 2018 | 113 | 0.140 |
Why?
|
| Male | 10 | 2026 | 31292 | 0.130 |
Why?
|
| Mutation | 3 | 2024 | 2670 | 0.130 |
Why?
|
| Female | 9 | 2026 | 34309 | 0.120 |
Why?
|
| Glucose | 1 | 2019 | 478 | 0.120 |
Why?
|
| Cells, Cultured | 1 | 2021 | 2189 | 0.120 |
Why?
|
| Capillary Permeability | 1 | 2015 | 17 | 0.120 |
Why?
|
| Lipid Peroxidation | 2 | 2026 | 67 | 0.120 |
Why?
|
| Metabolic Clearance Rate | 1 | 2015 | 48 | 0.120 |
Why?
|
| Adiponectin | 1 | 2015 | 37 | 0.110 |
Why?
|
| Mice, Inbred C3H | 1 | 2015 | 173 | 0.110 |
Why?
|
| Intra-Abdominal Fat | 1 | 2015 | 37 | 0.110 |
Why?
|
| Cadherins | 1 | 2015 | 90 | 0.110 |
Why?
|
| Tissue Distribution | 1 | 2015 | 292 | 0.110 |
Why?
|
| Image Enhancement | 1 | 2015 | 193 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 146 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 188 | 0.100 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2018 | 448 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2022 | 2168 | 0.100 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 2326 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2015 | 487 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 517 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 1172 | 0.090 |
Why?
|
| Diet, High-Fat | 2 | 2026 | 181 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2018 | 708 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 1715 | 0.080 |
Why?
|
| Models, Biological | 1 | 2015 | 1193 | 0.080 |
Why?
|
| Viral Proteins | 2 | 2022 | 270 | 0.070 |
Why?
|
| Genetic Therapy | 2 | 2026 | 852 | 0.070 |
Why?
|
| Lung | 2 | 2023 | 969 | 0.060 |
Why?
|
| Xanthine | 1 | 2026 | 2 | 0.060 |
Why?
|
| Factor IX | 1 | 2026 | 8 | 0.060 |
Why?
|
| Breath Tests | 1 | 2025 | 14 | 0.060 |
Why?
|
| Extracellular Vesicles | 1 | 2026 | 47 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2025 | 37 | 0.060 |
Why?
|
| Cathepsins | 1 | 2005 | 34 | 0.060 |
Why?
|
| Receptor, Notch3 | 1 | 2025 | 10 | 0.060 |
Why?
|
| Transgenes | 1 | 2026 | 207 | 0.060 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 39 | 0.060 |
Why?
|
| Kidney Tubules | 1 | 2024 | 23 | 0.050 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2025 | 76 | 0.050 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2025 | 46 | 0.050 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2024 | 25 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2025 | 1291 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2026 | 526 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2005 | 96 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2025 | 257 | 0.050 |
Why?
|
| Protein Binding | 2 | 2019 | 1633 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 180 | 0.050 |
Why?
|
| Islets of Langerhans | 1 | 2026 | 286 | 0.050 |
Why?
|
| trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride | 1 | 2024 | 1 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2005 | 179 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2025 | 115 | 0.050 |
Why?
|
| Phenotype | 2 | 2020 | 1235 | 0.050 |
Why?
|
| Fibrosis | 1 | 2025 | 172 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2026 | 218 | 0.050 |
Why?
|
| Collagen | 1 | 2025 | 135 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2026 | 322 | 0.050 |
Why?
|
| tau Proteins | 1 | 2025 | 212 | 0.050 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2023 | 8 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 115 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2025 | 219 | 0.050 |
Why?
|
| Chondrocytes | 1 | 2023 | 45 | 0.050 |
Why?
|
| Heart | 1 | 2025 | 298 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 269 | 0.050 |
Why?
|
| Integrins | 1 | 2023 | 109 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2005 | 239 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2025 | 215 | 0.050 |
Why?
|
| Pregnancy | 2 | 2021 | 2393 | 0.050 |
Why?
|
| Chemical Engineering | 1 | 2022 | 9 | 0.050 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 146 | 0.050 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2022 | 15 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2023 | 111 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2025 | 1389 | 0.050 |
Why?
|
| Endosomes | 1 | 2023 | 180 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2022 | 95 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 237 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2022 | 77 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 132 | 0.050 |
Why?
|
| Vitamins | 1 | 2022 | 80 | 0.050 |
Why?
|
| Immune Tolerance | 1 | 2023 | 186 | 0.040 |
Why?
|
| Sirolimus | 1 | 2022 | 93 | 0.040 |
Why?
|
| Interferons | 1 | 2022 | 74 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2023 | 165 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2022 | 153 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 2022 | 116 | 0.040 |
Why?
|
| Thermogenesis | 1 | 2022 | 128 | 0.040 |
Why?
|
| Amino Acids | 1 | 2022 | 148 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 126 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2022 | 266 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 316 | 0.040 |
Why?
|
| Blood Cell Count | 1 | 2021 | 33 | 0.040 |
Why?
|
| Tokyo | 1 | 2020 | 1 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 222 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 345 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2021 | 241 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 328 | 0.040 |
Why?
|
| Ornithine Decarboxylase | 1 | 2019 | 5 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 8 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 428 | 0.040 |
Why?
|
| Immobilized Proteins | 1 | 2019 | 6 | 0.040 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2019 | 17 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2019 | 24 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2019 | 116 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 427 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2019 | 102 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2020 | 145 | 0.040 |
Why?
|
| Dogs | 1 | 2020 | 324 | 0.040 |
Why?
|
| Placenta | 1 | 2019 | 70 | 0.040 |
Why?
|
| Phylogeny | 1 | 2020 | 399 | 0.040 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2019 | 20 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 113 | 0.040 |
Why?
|
| Deamination | 1 | 2018 | 11 | 0.040 |
Why?
|
| Inosine | 1 | 2018 | 5 | 0.040 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 206 | 0.040 |
Why?
|
| Pre-Eclampsia | 1 | 2019 | 72 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2018 | 96 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 137 | 0.040 |
Why?
|
| Pedigree | 1 | 2019 | 193 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2019 | 312 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2023 | 875 | 0.030 |
Why?
|
| Adenosine | 1 | 2018 | 79 | 0.030 |
Why?
|
| Seizures | 1 | 2019 | 141 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 312 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2018 | 342 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 119 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 768 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2019 | 506 | 0.030 |
Why?
|
| Homeostasis | 1 | 2019 | 383 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 1588 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2019 | 1042 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2029 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 797 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 364 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 674 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2019 | 2076 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2015 | 415 | 0.020 |
Why?
|
| Prognosis | 1 | 2015 | 1791 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 18439 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2496 | 0.020 |
Why?
|
| Child | 1 | 2019 | 4634 | 0.020 |
Why?
|
| Adult | 1 | 2026 | 17511 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4855 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2005 | 9 | 0.010 |
Why?
|
| Cathepsin L | 1 | 2005 | 21 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2005 | 14 | 0.010 |
Why?
|
| Myelin Proteins | 1 | 2005 | 30 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2005 | 25 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2005 | 108 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2005 | 130 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2005 | 220 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2005 | 241 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 15089 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2005 | 642 | 0.010 |
Why?
|